A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation.

MLA

Hansen, Morten Lock, et al. “A Danish Healthcare-Focused Economic Evaluation of First-Line Cryoballoon Ablation versus Antiarrhythmic Drug Therapy for the Treatment of Paroxysmal Atrial Fibrillation.” BMC Cardiovascular Disorders, vol. 24, no. 1, July 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12872-024-04024-5.

APA

Hansen, M. L., Moss, J. W. E., Tønnesen, J., Johansen, M. L., Kuniss, M., Ismyrloglou, E., Andrade, J., Wazni, O., Mealing, S., Sale, A., Afonso, D., Bromilow, T., Lane, E., & Chierchia, G. B. (2024). A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation. BMC Cardiovascular Disorders, 24(1), 1–10. https://doi.org/10.1186/s12872-024-04024-5

Chicago

Hansen, Morten Lock, Joe W. E. Moss, Jacob Tønnesen, Mette Lundsby Johansen, Malte Kuniss, Eleni Ismyrloglou, Jason Andrade, et al. 2024. “A Danish Healthcare-Focused Economic Evaluation of First-Line Cryoballoon Ablation versus Antiarrhythmic Drug Therapy for the Treatment of Paroxysmal Atrial Fibrillation.” BMC Cardiovascular Disorders 24 (1): 1–10. doi:10.1186/s12872-024-04024-5.